Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
OTM LIC nanoparticles for RF ablation
- Development stage
- Preclinical
- Lead developer
- Target Molecule
- Modality
- Nanoparticles → Drug Delivery Systems
- Administration
- Intravenous, Intra-arterial, Direct Injection
01
Overview
OTM LIC (Target Molecules Biotech Inc.) is developing a nanoparticle-based therapeutic designed to be used in conjunction with radiofrequency (RF) ablation for the treatment of unspecified cancers. These nanoparticles are intended to target cancer cells and enhance the thermal effects of RF ablation, potentially increasing the precision and efficacy of the procedure while minimizing damage to surrounding healthy tissue. The program is currently in the preclinical stage, specifically at the intellectual property (IP) filing stage. Technical details regarding the nanoparticle composition and specific molecular targets have not been disclosed by the developer.
- Other names
- Nanoparticles for RF Ablation
Beyond the preview
Go deeper on OTM LIC nanoparticles for RF ablation.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on OTM LIC nanoparticles for RF ablation.